SUPPORT AMERICAN FAITHDONATE NOW

Latest CDC VAERS Data Show Reported Injuries Surpass 400,000 Following COVID Vaccines

VAERS data released today by the CDC showed a total of 441,931 reports of adverse events from all age groups following COVID vaccines, including 6,985 deaths and 34,065 serious injuries between Dec. 14, 2020 and June 25, 2021.

This week’s number of total adverse events for all age groups following COVID vaccines surpassed 400,000, according to data released today by the Centers for Disease Control and Prevention (CDC). The data comes directly from reports submitted to the Vaccine Adverse Event Reporting System (VAERS).

VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.

Every Friday, VAERS makes public all vaccine injury reports received as of a specified date, usually about a week prior to the release date.

Data released today show that between Dec. 14, 2020 and June 25, 2021, a total of 411,931 total adverse events were reported to VAERS, including 6,985 deaths — an increase of 872 deaths over the previous week. There were 34,065 serious injury reports, up 2,825 compared with last week.

In the U.S, 321.2 million COVID vaccine doses had been administered as of June 25. This includes: 132 million doses of Moderna’s vaccine, 177 million doses of Pfizer and 12 million doses of the Johnson & Johnson (J&J) COVID vaccine.

Of the 6,985 deaths reported as of June 25, 22% occurred within 48 hours of vaccination, 15% occurred within 24 hours and 38% occurred in people who became ill within 48 hours of being vaccinated.

This week’s data for 12- to 17-year-olds show:

This week’s total VAERS data, from Dec. 14, 2020 to June 25, 2021, for all age groups show:

Pfizer to request emergency approval of COVID vaccine for kids ages 5-11 by fall

Fox News reported July 1, younger children could become eligible for a COVID vaccine this fall, according to a top executive at Pfizer who said the company has plans to request emergency approval of its vaccine in kids aged 5 to 11 by September or October. Pfizer’s vaccine is currently authorized for use in individuals aged 12 and older.

Dr. Alejandra Gurtman, vice president of vaccine clinical research and development at Pfizer, appeared along with representatives from other major drugmakers to discuss data and timelines behind pediatric clinical trials during a Johns Hopkins University and University of Washington virtual symposium.

Despite growing reports of heart inflammation in teens linked to the vaccine, Gurtman said Pfizer “felt very comfortable to move down in age,” speaking to the trials involving participants aged 6 months to 11 years.